HealthTree News

February 21, 2025

Jenny Ahlstrom shares her blood cancer journey and the creation of HealthTree Foundation on The Pulse podcast.

February 13, 2025

Read the clinical trial updates on a promising treatment combination that uses epcoritamab, rituximab, and lenalidomide. 

February 11, 2025

Explore glofitamab, a promising treatment for relapsed/refractory follicular lymphoma, offering fewer side effects and longer remission.

February 10, 2025

Explore side effects of bispecific antibodies for myeloma and B-cell lymphoma treatment, comparing brands on CRS, ICANS, and IEC-HS severity.

February 04, 2025

Discover how CAR T-cell therapy (tisagenlecleucel) performs in real-world follicular lymphoma patients with promising outcomes and safety.

February 04, 2025

HealthTree recognizes researchers with Innovation and Real-World Data Awards at ASH 2024, celebrating advancements in blood cancer research and patient care.

January 31, 2025

We are excited to announce the launch of the HealthTree Regional Cure Teams—an opportunity for individuals to volunteer in their communities.

January 31, 2025

If blood cancer patients are referred to receive CAR T-cell therapy, what barriers are keeping them from receiving it? Learn answers in this article.

January 28, 2025

The last few days have been chaos as a widespread federal freeze was ordered, affecting cancer research. The order has been reversed.

January 23, 2025

Learn about secondary CNS involvement in large B-cell lymphoma, its diagnosis, treatments, and hope for improved outcomes.